Why the study?
Do implantable cardioverter-defibrillators provide appropriate therapy and what are the complication rates in adults with congenital heart disease?
Do implantable cardioverter-defibrillators provide appropriate therapy and what are the complication rates in adults with congenital heart disease?
ICDs in adults with congenital heart disease provide high rates of appropriate therapy but are associated with significant inappropriate shocks and complications, necessitating individualized risk-benefit assessment.
Answers are grounded in this paper and cite their sources.
Necessitates individualized ICD risk-benefit assessment in adults with congenital heart disease; extends pooled evidence on therapy and complication rates.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vehmeijer et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: